Peer Review reports
From: tRNA-derived fragments as novel potential biomarkers for relapsed/refractory multiple myeloma
Original Submission | ||
---|---|---|
2 Jan 2021 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
Resubmission - Version 3 | ||
Submitted | Manuscript version 3 | |
5 Feb 2021 | Reviewed | Reviewer Report |
13 Feb 2021 | Reviewed | Reviewer Report |
26 Feb 2021 | Author responded | Author comments - Yunfeng Fu |
Resubmission - Version 4 | ||
26 Feb 2021 | Submitted | Manuscript version 4 |
27 Feb 2021 | Reviewed | Reviewer Report |
3 Mar 2021 | Reviewed | Reviewer Report |
13 Mar 2021 | Author responded | Author comments - Yunfeng Fu |
Resubmission - Version 5 | ||
13 Mar 2021 | Submitted | Manuscript version 5 |
17 Mar 2021 | Reviewed | Reviewer Report |
20 Mar 2021 | Reviewed | Reviewer Report |
22 Mar 2021 | Author responded | Author comments - Yunfeng Fu |
Resubmission - Version 6 | ||
22 Mar 2021 | Submitted | Manuscript version 6 |
Resubmission - Version 7 | ||
Submitted | Manuscript version 7 | |
2 Apr 2021 | Author responded | Author comments - Yunfeng Fu |
Resubmission - Version 8 | ||
2 Apr 2021 | Submitted | Manuscript version 8 |
9 Apr 2021 | Author responded | Author comments - Yunfeng Fu |
Resubmission - Version 9 | ||
9 Apr 2021 | Submitted | Manuscript version 9 |
11 Apr 2021 | Reviewed | Reviewer Report |
12 Apr 2021 | Reviewed | Reviewer Report |
24 Apr 2021 | Author responded | Author comments - Yunfeng Fu |
Resubmission - Version 10 | ||
24 Apr 2021 | Submitted | Manuscript version 10 |
27 Apr 2021 | Author responded | Author comments - Yunfeng Fu |
Resubmission - Version 11 | ||
27 Apr 2021 | Submitted | Manuscript version 11 |
28 Apr 2021 | Reviewed | Reviewer Report |
29 Apr 2021 | Reviewed | Reviewer Report |
Resubmission - Version 12 | ||
Submitted | Manuscript version 12 | |
Publishing | ||
4 May 2021 | Editorially accepted | |
11 May 2021 | Article published | 10.1186/s12859-021-04167-8 |
You can find further information about peer review here.